Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLAMF8 |
| Upstream (Parents) |
|---|
| (<<) SLC1A3 → SLAMF8 |
| (<<) FCGR1C///FCGR1A → SLAMF8 |
| (<<) FCGR1B → SLAMF8 |
| (<<) LILRB4 → SLAMF8 |
| (<<) RAB31 → SLAMF8 |
| Downstream (Children) |
|---|
| SLAMF8 → SLC1A3 (>>) |
| SLAMF8 → LILRA6///LILRB3 (>>) |
| SLAMF8 → LILRB4 (>>) |
| SLAMF8 → TSPAN12 (>>) |
| SLAMF8 → HLA-G (>>) |
| SLAMF8 → ADAMDEC1 (>>) |
| SLAMF8 → CCL18 (>>) |
| SLAMF8 → CCL11 (>>) |
| SLAMF8 → PIK3CG (>>) |
| SLAMF8 → RENBP (>>) |
| SLAMF8 → MAPK11 (>>) |
| SLAMF8 → CCL2 (>>) |
| SLAMF8 → SIGLEC9 (>>) |
| SLAMF8 → GDAP1L1 (>>) |
| SLAMF8 → GAS7 (>>) |
| SLAMF8 → HLA-F (>>) |
| SLAMF8 → CCL3L3///CCL3L1///CCL3 (>>) |
